← Evidence map

ArticleUrology practice2026

Patient-Reported Outcomes Following UGN-102 Treatment in Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: An Analysis of 3 Clinical Trials.

Charles C Peyton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Patient-Reported Outcomes Following UGN-102 Treatment in Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: An Analysis of 3 Clinical Trials. | OpenQuestion